Home » Keryx Kidney Drug Meets Goals in Midstage Study
Keryx Kidney Drug Meets Goals in Midstage Study
Keryx Biopharmaceuticals Inc. said its developing kidney disease drug Zerenex met safety and tolerability goals in a midstage study.
Yahoo! Finance
Yahoo! Finance
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May